Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer
Completed · Not applicable · Has a placebo group
Conditions studied: Prostate Cancer
In brief
RATIONALE: The use of lycopene, a substance found in tomatoes, or omega-3 fatty acid nutritional supplements may keep cancer from growing in patients with prostate cancer. PURPOSE: This randomized clinical trial is studying lycopene to see how well it works compared to omega-3 fatty acids or a placebo in treating patients with stage I or stage II prostate cancer.
Key facts
- Study ID
- NCT00402285
- Run by
- University of California, San Francisco
- People needed
- 84
- Starts
- 2003-04-01
- Expected to finish
- 2008-01-01
- Last updated by the study team
- 2016-01-01
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
Where it is running
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.